Encompass Health - 15 Year Stock Price History | EHC
Historical daily share price chart and data for Encompass Health since 2011 adjusted for splits and dividends. The latest closing stock price for Encompass Health as of June 18, 2026 is 98.03.
- The all-time high Encompass Health stock closing price was 126.70 on October 27, 2025.
- The Encompass Health 52-week high stock price is 127.99, which is 30.6% above the current share price.
- The Encompass Health 52-week low stock price is 92.77, which is 5.4% below the current share price.
- The average Encompass Health stock price for the last 52 weeks is 110.95.
| Encompass Health Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2026 | 103.1082 | 106.1610 | 113.2070 | 93.6457 | 98.0300 | -7.29% |
| 2025 | 111.2530 | 91.0888 | 126.7030 | 90.2954 | 105.7420 | 15.67% |
| 2024 | 85.3832 | 66.1200 | 102.7210 | 65.8443 | 91.4161 | 39.17% |
| 2023 | 62.3015 | 57.9843 | 70.3836 | 50.2706 | 65.6868 | 12.62% |
| 2022 | 50.2394 | 51.0779 | 58.3257 | 41.3949 | 58.3257 | 17.01% |
| 2021 | 58.5020 | 61.9666 | 66.9341 | 43.0498 | 49.8481 | -19.90% |
| 2020 | 51.9114 | 51.1717 | 64.4634 | 37.0469 | 62.2300 | 21.42% |
| 2019 | 46.8815 | 44.5453 | 53.1240 | 42.1514 | 51.2530 | 14.26% |
| 2018 | 47.7115 | 36.7622 | 59.3985 | 35.5387 | 44.8580 | 26.89% |
| 2017 | 31.7897 | 29.1450 | 35.6656 | 27.0502 | 35.3527 | 22.36% |
| 2016 | 26.8893 | 23.7159 | 29.8119 | 21.1439 | 28.8928 | 21.34% |
| 2015 | 27.9538 | 24.7285 | 31.9585 | 22.2666 | 23.8117 | -6.71% |
| 2014 | 23.8270 | 21.6206 | 27.5543 | 19.5222 | 25.5250 | 17.92% |
| 2013 | 19.3077 | 14.2373 | 23.5716 | 14.1538 | 21.6467 | 59.53% |
| 2012 | 13.7516 | 11.3899 | 15.8314 | 10.8114 | 13.5689 | 19.47% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $10.662B | $5.935B |
| Encompass Health Corporation is a provider of integrated healthcare services. It offers both facility-based and home-based patient care through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The company delivers high-quality, cost-effective, integrated care in the healthcare space. It provides a continuum of facility-based and home-based post-acute services for its patients and their families, which will gain more prevalence as coordinated care and integrated delivery payment models, such as accountable care organizations and bundled payment arrangements. The company operates through two segments: Inpatient Rehabilitation as well as Home Health and Hospice business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |